Regulation
Regulora delivers behavioral therapy based on gut-directed hypnotherapy through a smartphone app.
The InVisionOS officially received the clearance earlier this month and will be available in early 2022.
The stock took a tumble in October following the letter.
The regulation will enable joint clinical assessments between EU member states.
This news comes just weeks after Philips announced its plans to acquire Cardiologs.
The news comes just as Pear is finalizing its SPAC merger.
The news comes about a week after AppliedVR announced it raised $36 million in Series B funding.
The tool will be part of the EPIQ Elite and Affiniti systems.
Ellume began recalling the tests last month for giving false positive results.
Detect uses an app to help users perform the test and interpret the results.